Malin invests in and supports highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders.
Our purpose is to create shareholder value through the application of long-term capital and strategic support to our investee companies to enable them to reach their value potential.
Vision: To deliver significant returns for our shareholders and transformative outcomes for patients by investing in and supporting highly innovative life sciences companies
2014
Served areaEurope
43,634,607
IPOMarch 25, 2015
Stock exchange(s)Euronext Dublin